MOR Wealth Management’s Amgen AMGN Stock Holding History

MOR Wealth Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-850	Closed	-$299K	–	123
2026 Q1	$299K	Buy	+850	New	+$303K	0.14%	77

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

MOR Wealth Management's AMGN Position: Q2 2026 in Review

MOR Wealth Management sold out of Amgen (AMGN) in Q2 2026, closing a stake of 850 shares — an estimated $299K sold.

MOR Wealth Management first reported a position in AMGN in Q1 2026 and held it in 1 quarter. The position peaked at $299K in Q1 2026. 3,133 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

MOR Wealth Management reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
MOR Wealth Management sold 850 Amgen shares in Q2 2026, an estimated $299K.
MOR Wealth Management first reported a position in Amgen in Q1 2026 and held it in 1 quarter.
MOR Wealth Management's Amgen position peaked at $299K in Q1 2026.
3,133 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on MOR Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.